Skip to Main Content

20-443 New Prior Authorization Requirements

Date: 06/08/20

Request prior authorizations for medications listed in this update

Please review the medications in this update to find out when you need to request prior authorization (PA) for California Health & Wellness Plan (CHWP) members.

Medications requiring PA immediately

The below medications require PA immediately per new injectable medication HCPCS codes issued by the Centers for Medicare & Medicaid Services (CMS) on April 1, 2020:

  • Adakveo®
  • Givlaari®

New PA requirements starting August 11, 2020

All providers must request PA for the medications listed below:

Erbitux®

Ozurdex®

Triptodur®

Vyondys 53®

Faslodex®

Panhematin®

Vectibix®

Zaltrap®

Mozobil®

Synribo®

Vidaza®

 

View PA requirements online

Prior authorization requirements are available on www.CAHealthWellness.com.

Providers participating through the Community Care Independent Practice Association (CCIPA) must contact CCIPA, follow CCIPA’s prior authorization process and use CCIPA’s forms.

Additional information

If you have questions regarding the information contained in this update, contact CHWP at 1-877-658-0305.